1-11 of 11
Takeshi Yamashita
Close
Sort by
Journal Articles

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy

Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Ayumi Kuzume, Yuya Kamura, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Takeshi Yamashita, Hiroyuki Takamatsu, Kosei Matsue
Journal: Blood
Blood (2022) 140 (Supplement 1): 9277–9278.
https://doi.org/10.1182/blood-2022-168823
Published: 2022
Journal Articles

Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma

Hiroyuki Takamatsu, Daisuke Ikeda, Toshiki Terao, Takeshi Yamashita, Ryota Urushihara, Yuzuki Hatano, Nana Hirose, Natsu Yamada, Ryoichi Murata, Toshihiro Miyamoto, Kosei Matsue
Journal: Blood
Blood (2022) 140 (Supplement 1): 1828–1829.
https://doi.org/10.1182/blood-2022-158721
Published: 2022
Journal Articles

Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting

Takeshi Yoroidaka, Hiroyuki Takamatsu, Mitsuhiro Itagaki, Satoshi Yoshihara, Kota Sato, Naoki Takezako, Shuji Ozaki, Kazuhito Suzuki, Kentaro Kohno, Morio Matsumoto, Yasushi Terasaki, Takeshi Yamashita, Shin-ichi Fuchida, Ryota Urushihara, Yuji Hiragori, Kenshi Suzuki, Hirokazu Murakami, Shinji Nakao, Brian G.M. Durie, Kazuyuki Shimizu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3946.
https://doi.org/10.1182/blood-2021-146441
Published: 2021
Journal Articles

Comparison of MRD Detection in Autografts in Multiple Myeloma between Novel High-Sensitivity Euroflow-NGF and NGS

Ryota Urushihara, Naoki Takezako, Takeshi Yoroidaka, Takeshi Yamashita, Shinji Nakao, Hiroyuki Takamatsu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3950.
https://doi.org/10.1182/blood-2021-149041
Published: 2021
Journal Articles

Minimal Residual Disease in Autografts and Bone Marrow of Patients with Multiple Myeloma: 8-Color Multiparameter Flow Cytometry (EuroFlow-NGF) Vs . Next-Generation Sequencing

Hiroyuki Takamatsu, MDPhD, Naoki Takezako, MDPhD, Takeshi Yoroidaka, MD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Atsuko Yamazaki, MD, Masahiro Takeuchi, MD PhD, Naoya Mimura, MD PhD, Chiaki Nakaseko, MD PhD, Emiko Sakaida, MDPhD, Masahiro Onoda, MD, Yoshikazu Utsu, MD PhD, Motoharu Fukazawa, MD, Kosei Matsue, MDPhD, Shinji Nakao, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-137014
Published: 2020
Journal Articles

Comparison of Minimal Residual Disease Detection between the Manual and Automated Gating Strategies of Euroflow Next-Generation Flow in Patients with Multiple Myeloma

Hiroyuki Takamatsu, MD PhD, Takeshi Yoroidaka, MD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Mikio Ueda, MD PhD, Shinji Nakao, MD PhD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3083.
https://doi.org/10.1182/blood-2019-122398
Published: 2019
Journal Articles

Minimal Residual Disease Assessment Using Euroflow-NGF in Patients with Multiple Myeloma Treated with a Combination of Carfilzomib, Lenalidomide, and Dexamethasone (KRD)

Takeshi Yoroidaka, MD, Hiroyuki Takamatsu, MD PhD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Kyoko Yoshihara, MD PhD, Satoshi Yoshihara, MD PhD, Mikio Ueda, MD PhD, Shinji Nakao, MD PhD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3130.
https://doi.org/10.1182/blood-2019-126552
Published: 2019
Journal Articles

Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing

Hiroyuki Takamatsu, MDPhD, Naoki Takezako, MD PhD, Rachel K Wee, Takeshi Yoroidaka, MD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Kosei Matsue, MD PhD, Shinji Nakao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 258.
https://doi.org/10.1182/blood-2018-99-111250
Published: 2018
Journal Articles

Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan

Takeshi Yamashita, MD, Hiroyuki Takamatsu, MD PhD, Koji Kawamura, MD, Kazutaka Sunami, MD PhD, Shotaro Hagiwara, MD, Grad Dip Clin Epid., PhD, Mitsuhiro Itagaki, MD, Tsutomu Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Takashi Ikeda, MD PhD, Kyoko Watakabe-Inamoto, MD, Hiroshi Handa, MD PhD, Yoshitaka Imaizumi, MD PhD, Junya Kuroda, MD PhD, Jun Murakami, MD PhD, Yuichi Nakamura, MD PhD, Hideyuki Nakazawa, MD PhD, Shuji Ozaki, MD PhD, Shinji Nakao, MD PhD, Kensei Tobinai, MD, PhD, Shinsuke Iida, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4493.
https://doi.org/10.1182/blood.V128.22.4493.4493
Published: 2016
Journal Articles

Efficacy and Safety of Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism Following Total Hip Arthroplasty: STARS J-V trial

Takeshi Fuji, Satoru Fujita, Shintaro Tachibana, Yohko Kawai, Yukihiro Koretsune, Takeshi Yamashita, Mashio Nakamura
Journal: Blood
Blood (2010) 116 (21): 3320.
https://doi.org/10.1182/blood.V116.21.3320.3320
Published: 2010
Journal Articles

Asymptomatic Intracranial Hemorrhage Among Japanese Patients Taking Edoxaban for Non-Valvular Atrial Fibrillation.

Masahiro Yasaka, Hiroshi Inoue, Yohko Kawai, Takenori Yamaguchi, Shinichiro Uchiyama, Masayasu Matsumoto, Satoshi Ogawa, Yukihiro Koretsune, Takeshi Yamashita
Journal: Blood
Blood (2009) 114 (22): 1066.
https://doi.org/10.1182/blood.V114.22.1066.1066
Published: 2009